August 3, 2012 Race against a million deaths begins at Tucson’s C-Path When I’ll Have Another won the Kentucky Derby in May, no one talked about the hundreds of millions of dollars each year that
August 1, 2012 Revisiting the multiple sclerosis functional composite: proceedings from the National Multiple Sclerosis Society (NMSS) Task Force on Clinical Disability Measures
July 27, 2012 Approval of new drugs slowing Fewer new prescription drugs will get approved in the U.S. this year than the 30 approved in 2011, a ratings agency forecasts, add
July 10, 2012 Tucson tech: Tucson’s C-Path drug institute looks to boost its future funding Tucson’s Critical Path Institute recently got some good news – and some noteworthy recognition – when the U.S. S
June 22, 2012 CDISC, C-Path and FDA Collaborate to Develop Data Standards to Streamline Path to New Therapies The Clinical Data Interchange Standards Consortium (CDISC) and the Critical Path Institute (C-Path) announce the signing of a part
May 19, 2012 Using Translatability Assessment to Refine a Patient-Reported Outcome (PRO) Measure During The Development Process
May 16, 2012 Stakeholders Share Data to Design Better Trials for Neurodegenerative Diseases The Coalition Against Major Diseases is pooling clinical data to build disease and drug models.
May 15, 2012 Tuberculosis Diagnostics and Biomarkers: Needs, Challenges, Recent Advances, and Opportunities